We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

DNX and XL-protein Announce Collaboration

News   Jul 02, 2015

 
DNX and XL-protein Announce Collaboration
 
 
Advertisement
 

RELATED ARTICLES

Biologic Therapy for Psoriasis May Also Have Applications in Heart Disease

News

Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research.

READ MORE

Tiny Antibody Component Neutralizes SARS-CoV-2 in Animal Models

News

Scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes SARS-CoV-2. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug, called Ab8, which holds potential as a therapeutic and prophylactic against SARS-CoV-2.

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE